Occipital neuralgia is a condition characterised by pain in the distribution of the occipital nerves. When conservative and medical management proves insufficient, an interventional approach becomes the next step — and structured protocols define precisely when and how to escalate to it.
For medically refractory occipital neuralgia, the recommended first invasive approach involves a targeted nerve block at the greater occipital nerve using a local anesthetic agent. The block may be performed with a single agent or in combination — the specific agent selection, adjuncts, and procedural parameters are defined in the full protocol.
The primary therapeutic aim is temporary relief of occipital pain. Published literature indicates that pain relief is achieved in the majority of treated cases, with duration of effect that may vary by approach and agent used.
DOI: 10.1055/s-0040-1716451
This is the first invasive modality to be offered in medically refractory cases.
Local anesthetics especially; Lignocaine (1%, 2% and 5%)/Bupivacaine (0.25–0.5%), either in isolation or with Steroid (methyl prednisolone/Betamethasone/Triamcinolone) combinations along with clonidine/epinephrine have been tried in the literature.
The pain relief although reported temporary in 80–90% of cases persisting for up to 1–2 weeks.
View source ↗